Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) presented as an active mover, shares increased 1.94% to traded at $3.67 in most recent trading session. The firm has floated short ratio of 30.74%, hold to candle to sentiment indicator of Short Ratio, its stand at 11.73. The gross profit margin can be giving more focus view that is 96.50% respectively.
Turns back to returns ratios, returns on equity stands at 80.60%. Usually, financial analysts consider return on equity ratios in the 15-20% range as an attractive level of investment quality. Narrow down focus to firm performance, its weekly performance was -10.05% and monthly performance was -32.16%. The stock price of MACK is moving down from its 20 days moving average with -21.07% and isolated negatively from 50 days moving average with -30.92%.
Following analysis criteria, Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) attains noticeable attention, it moving down -1.17% to traded at $0.30. PPHM attains analyst recommendation of 1.50 on scale of 1-5 with week’s performance of -4.35%.
The firm has noticeable returns on equity ratio of -101.00%, which shows how much profit each dollar of ordinary stockholders’ equity generates. The returns on investment very popular metric among passive investors, it stands at -112.50%. To see the other side of depiction, profit margin of PPHM stands at negative -89.50%; that indicates a firm actually every dollar of sales keeps in earnings. The -43.90% returns on assets presents notable condition of firm. Mostly ROA known as a comparative measure, it is best to compare it against a firm’s previous ROA numbers or the ROA of a same firm.
To find out the technical position of PPHM, it holds price to book ratio of 1.74 that unearth high-growth companies selling at low-growth prices, but it requires appropriate measurement approach. PPHM is presenting price to cash flow of 1.55.